Skip to content

Alcohol Detection Via Bioimpedance Mesurements

Alcohol Detection Via Bioimpedance Mesurements

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01977157
Acronym
AlkBIS
Enrollment
12
Registered
2013-11-06
Start date
2012-07-31
Completion date
2013-10-31
Last updated
2013-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Impedance cardiography, bioimpedance, spectroscopy, extracellular resistance, body composition, hemodynamics, alcohol

Brief summary

Examination if the bioimpendanz measurement can be used for the determination of the alcohol content in human blood. Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer and one blood test.

Detailed description

In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo). This technology is non-invasive an can be measured by using conductive electrodes, capacitive electrodes or inductive measurement systems. The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK III, Dräger, Lübeck, Germany). Furthermore one blood sample will be taken and analyzed with the ADH method as the current gold standard at the end of the trail.

Interventions

DEVICEbioimpedance mesurements

Bioimpedance measurements were conducted with a BIS device (SFB7, ImpediMed, Pinkeba, Australia) covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo, medis, Ilmenau, Germany)

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male subjects * able to give informed consent * Inconspicuous laboratory and drug screening

Exclusion criteria

* electrophobica * alcoholphobica, -allergy * metallic ans / or electric implants * underage persons * interactively medication

Design outcomes

Primary

MeasureTime frameDescription
Bioimpedance measurements4 hoursEvaluation if the bioimpedance measurements can be used to verify and quantify the alcohol content in human blood. Bioimpedance measurements will be conducted with the BIS device (SFB7, ImpediMed) covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo,medis) operating at. The whole-body and hand-to-hand bioimpedance will be analyzed. Extracellular resistance (Re), intracellular resistance (Ri) and capacitive effects (Cm) are calculated by using the Cole model Grimnes (2000).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026